케어젠

214370KOSDAQ기초 의약물질 제조업

41.5 / 100

Reference Date: 2026-07-24

Financial Score11.5 / 40

News Sentiment18.0 / 25

Momentum3.0 / 20

Disclosure9.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Plunged 19.9% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Caregen develops and sells pharmaceuticals, health supplements, medical devices, and cosmetics based on biomimetic peptides and growth factor proteins, leveraging a large peptide library with over 860 patents. The company offers key products such as blood sugar regulators, muscle health supplements, and weight management solutions, and is expanding into new drug pipelines for conditions like macular degeneration, diabetes, and hair loss through global sales in 130 countries.

Number of Employees

201people

Average Salary

50.8M KRW

Score Calculation Basis

Detailed Financial Score

PER

140.15Industry Average 25.440.0Point

5.5x industry avg (risky)

PBR

14.56Industry Average 1.260.0Point

11.6x industry avg (risky)

ROE

9.23Industry Average -6.033.5Point

Well below industry avg

Debt Ratio

4.90Industry Average 6.625.0Point

Lower than industry avg (good)

Trend 2023~20253.0 / 10 points

Revenue Growth Rate

0.5 / 3

Avg ▼3.8% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼27.8% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 13.9% (declining, 3yr)

Detailed News Sentiment

5 totalPositive 3Neutral 1Negative 1Average Sentiment Score 72

Neutral
100대 기업 임원 평균 54.2세…젊은 임원 줄고 '50대 이상' ...
General trend shows aging leadership across top companies except for Naver, impacting overall market perception without direct stock impact.
Positive
인제니아 코스닥 상장 추진에 재조명되는 51조 망막질환 치료제 시장
인제니아테라퓨틱스의 코스닥 상장 추진 소식으로 망막질환 치료제 시장에서의 성장 기대감이 높아짐.
Negative
삼전 최대 실적에도…코스피 하락 출발
코스피 하락으로 인해 케어젠을 포함한 관련 주식들의 부정적 영향 예상.

Detailed Momentum

52-week position1.0Point

Near 52w low (11%, downtrend)

Current 57,600Won52-week high 150,10052-week low 45,950

1-month return0.0Point

1m -19.89% (strong drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

4 totalPositive 1Neutral 2Negative 1

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-10
Neutral주식등의대량보유상황보고서(일반)2026-07-08
Positive현금ㆍ현물배당결정 (중간배당)2026-07-03
Negative불성실공시법인지정 (공시번복 1건, 공시변경 1건)2026-06-29